These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29990983)

  • 1. Extracellular Vesicles as a Platform for Glioma Therapeutic Development.
    Santiago-Dieppa DR; Gonda DD; Cheung VJ; Steinberg JA; Carter BS; Chen CC
    Prog Neurol Surg; 2018; 32():172-179. PubMed ID: 29990983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma-Derived Extracellular Vesicles - Far More Than Local Mediators.
    Tankov S; Walker PR
    Front Immunol; 2021; 12():679954. PubMed ID: 34135908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
    Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS
    Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ExRNA in Biofluids as Biomarkers for Brain Tumors.
    Rennert RC; Hochberg FH; Carter BS
    Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers of glioma: recent advance and potential applications].
    Yu SZ; Wang Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extracellular vesicles for diagnosis and therapy of gliomas: problems and opportunities].
    Filin AA; Chernysheva AA; Pavlova GV; Loshhenov VB; Gurina OI
    Biomed Khim; 2022 Dec; 68(6):419-426. PubMed ID: 36573408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Extracellular Vesicles in Glioma Progression: Deciphering Cellular Biological Processes to Clinical Applications.
    Rana R; Joon S; Chauhan K; Rathi V; Ganguly NK; Kumari C; Yadav DK
    Curr Top Med Chem; 2021; 21(8):696-704. PubMed ID: 33292136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.
    Skouras P; Gargalionis AN; Piperi C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-oncology: diagnosis and management of cerebral gliomas--past, present, and future.
    Gutin PH; Posner JB
    Neurosurgery; 2000 Jul; 47(1):1-8. PubMed ID: 10917341
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of extracellular vesicles in glioma progression.
    Quezada C; Torres Á; Niechi I; Uribe D; Contreras-Duarte S; Toledo F; San Martín R; Gutiérrez J; Sobrevia L
    Mol Aspects Med; 2018 Apr; 60():38-51. PubMed ID: 29222067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating biomarkers for high-grade glioma.
    Loo HK; Mathen P; Lee J; Camphausen K
    Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma EVs Contribute to Immune Privilege in the Brain.
    Abels ER; Broekman MLD; Breakefield XO; Maas SLN
    Trends Cancer; 2019 Jul; 5(7):393-396. PubMed ID: 31311653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
    Wen PY; Reardon DA
    Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
    [No Abstract]   [Full Text] [Related]  

  • 16. Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics.
    Indira Chandran V; Welinder C; Gonçalves de Oliveira K; Cerezo-Magaña M; Månsson AS; Johansson MC; Marko-Varga G; Belting M
    J Neurooncol; 2019 Sep; 144(3):477-488. PubMed ID: 31414377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Exosomes in the Progression, Diagnosis, and Treatment of Gliomas.
    Shi J; Zhang Y; Yao B; Sun P; Hao Y; Piao H; Zhao X
    Med Sci Monit; 2020 Nov; 26():e924023. PubMed ID: 33245712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma.
    Indira Chandran V; Welinder C; Månsson AS; Offer S; Freyhult E; Pernemalm M; Lund SM; Pedersen S; Lehtiö J; Marko-Varga G; Johansson MC; Englund E; Sundgren PC; Belting M
    Clin Cancer Res; 2019 May; 25(10):3115-3127. PubMed ID: 30679164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target.
    Almiron Bonnin DA; Havrda MC; Israel MA
    Cancer Res; 2018 Nov; 78(21):6031-6039. PubMed ID: 30333116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.
    Schiera G; Di Liegro CM; Di Liegro I
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.